22.9 Evidence Behind the Case

Time To Read

3–5 minutes

Date Last Modified

Module 22 is where every clue snaps into one picture: two MEFV mutations → a hair-trigger pyrin inflammasome → IL-1β surges that drove the fevers, the serositis, the bone turnover, the neuropathy, and — through chronically elevated SAA — the AA amyloid in her gut and kidneys. FMF is autoinflammatory, not autoimmune.

This page belongs to a teaching case built around familial Mediterranean fever (FMF). If you found it searching one of these, it is a valid, evidence-anchored starting point — and it names the single pathway behind the whole case.

Jump to it:

The capstone. Genetic testing confirmed two mutations in MEFV, the gene for pyrin — part of the innate immune system’s inflammasome. Stina’s pyrin is hair-trigger: tiny provocations set off the IL-1β surges that, over a lifetime, drove her fevers, her serositis, her bone turnover, her neuropathy, and, through chronically elevated liver-made SAA, the AA amyloid now in her gut and kidneys. On colchicine and an IL-1 blocker, her SAA falls and her proteinuria stabilizes. Stina is me — and this is the mechanism behind all twenty Chart Clues.

FMF is the prototype autoinflammatory disease, defined against autoimmunity by its innate-immune, inflammasome-driven, antibody-independent mechanism.1,2 The pyrin inflammasome, when MEFV-mutant, over-produces IL-1β3 — which is why IL-1 blockade (anakinra, canakinumab) controls colchicine-resistant disease4,5 and why colchicine, which gates pyrin, is first-line. The through-line is the amyloid cascade: IL-1β/IL-6 → liver SAA → AA amyloid, organ by organ. (Your course also threads a mannose-binding-lectin subplot; MBL deficiency raising infection susceptibility is general immunology,6 separate from the FMF autoinflammation.)

If you reached this page searching autoinflammatory versus autoimmune disease, the pyrin inflammasome, or IL-1 blockade for FMF, that is the page doing its job: it names the single pathway that made a lifetime of scattered clues one connected story.

CHART CLUE #20

A lifetime of episodic fever, serositis, multi-system inflammation, and AA amyloidosis is explained by one pyrin/inflammasome defect over-producing IL-1β.

THE DISTINCTION

FMF is innate-immune and inflammasome-driven, not antibody-mediated autoimmunity — a distinction that recolors the whole case.

MEFV

Mutant pyrin lowers the inflammasome threshold, driving IL-1β overproduction.

TREATMENT

IL-1 blockade (anakinra, canakinumab) controls colchicine-resistant FMF; colchicine gates pyrin and is first-line.

COURSE THREAD

Mannose-binding-lectin deficiency raises infection susceptibility — a separate innate-immunity thread, not part of the FMF autoinflammation.

Stina is not a composite. Stina is me. The double feeling of the diagnosis call — relief and grief at once — was mine, and so is this ending: a single gene, a single protein, a single pathway that had been writing my whole chart in plain sight.

This page holds both truths at once. The lived experience — a lifetime told these symptoms weren’t connected — is the part a chart never records. The research support is what earns the case a place in a science course: the mechanism, the drugs, and the autoinflammatory framing are all cited, and the MBL subplot is flagged as separate. If you are a clinician who arrived from a patient, treat this as a validated starting point — and read the whole chart at once.

  1. A clinical guide to autoinflammatory diseases: FMF and next-of-kin. Nat Rev Rheumatol 2013.
  2. Familial Mediterranean fever: an autoinflammatory genetic disorder (review). 2024.
  3. The pyrin inflammasome in health and disease. Front Immunol 2019.

Inflammation reaches reproduction — Chart Clue #19.

Five rashes, one fire — the skin as billboard.

Proteinuria is the alarm — Chart Clue #17.

The needless appendectomy — Chart Clue #1.

List of terms